Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody Treatment
Clinical trial NCT04558918 · COMPLETED
Trial details
- NCT number
- NCT04558918
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-25
- Primary completion
- 2022-09-26
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.